{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:45:39Z","timestamp":1769633139139,"version":"3.49.0"},"reference-count":41,"publisher":"IMR Press","issue":"3","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Septal myectomy is indicated in patients with obstructive hypertrophic cardiomyopathy (HCM) and intractable symptoms. Concomitant mitral valve (MV) surgery is performed for abnormalities contributing to systolic anterior motion (SAM), or for SAM-mediated mitral regurgitation (MR) with or without left ventricular outflow tract (LVOT) obstruction. One MV repair technique is anterior mitral leaflet extension (AMLE) utilizing bovine pericardium, stiffening the leaflet and enhancing coaptation posteriorly. Fifteen HCM patients who underwent combined myectomy-AMLE for LVOT obstruction or moderate-to-severe MR between 2009 and 2020 were analyzed using detailed echocardiography. The mean age was 56.6 years and 67% were female. The average peak systolic LVOT gradient and MR grade measured 73.4 mmHg and 2.3, respectively. Indications for myectomy-AMLE were LVOT obstruction and moderate-to-severe MR in 67%, MR only in 20%, and LVOT obstruction only in 13%. There was no mortality observed, and median follow-up was 1.2 years. Two patients had follow-up grade 1 mitral SAM, one of whom also had mild LVOT obstruction. No recurrent MR was observed in 93%, and mild MR in 7%. Compared with preoperative measures, there was a decrease in follow-up LV ejection fraction (68.2 vs 56.3%, p = 0.02) and maximal septal wall thickness (25.5 vs 21.3 mm, p &lt; 0.001), and an increase in the end-diastolic diameter (21.9 vs 24.8 mm\/m2, p = 0.04). There was no change in global longitudinal strain (\u201312.1 vs \u201311.6%, p = 0.73) and peak LV twist (7.4 vs 7.3\u2218, p = 0.97). In conclusion, myectomy-AMLE is a viable treatment option for carefully selected symptomatic HCM patients with LVOT obstruction or moderate-to-severe MR.<\/jats:p>","DOI":"10.31083\/j.rcm2203107","type":"journal-article","created":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T02:35:45Z","timestamp":1632623745000},"source":"Crossref","is-referenced-by-count":10,"title":["Echocardiographic and clinical outcomes of patients undergoing septal myectomy plus anterior mitral leaflet extension for hypertrophic cardiomyopathy"],"prefix":"10.31083","volume":"22","author":[{"given":"Rafle","family":"Fernandez","sequence":"first","affiliation":[{"name":"Echocardiography Laboratory, Columbia University Division of Cardiology, Mount Sinai Heart Institute, Miami Beach, FL 33140, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Nappi","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, Centre Cardiologique du Nord de Saint-Denis, 93200 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia A.","family":"Horvath","sequence":"first","affiliation":[{"name":"Echocardiography Laboratory, Columbia University Division of Cardiology, Mount Sinai Heart Institute, Miami Beach, FL 33140, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Guigui","sequence":"first","affiliation":[{"name":"Echocardiography Laboratory, Columbia University Division of Cardiology, Mount Sinai Heart Institute, Miami Beach, FL 33140, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos G.","family":"Mihos","sequence":"first","affiliation":[{"name":"Echocardiography Laboratory, Columbia University Division of Cardiology, Mount Sinai Heart Institute, Miami Beach, FL 33140, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, et al. Hypertrophic Cardiomyopathy is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction. Circulation. 2006; 114: 2232\u20132239.","DOI":"10.1161\/CIRCULATIONAHA.106.644682"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Ro R, Halpern D, Sahn DJ, Homel P, Arabadjian M, Lopresto C, et al. Vector Flow Mapping in Obstructive Hypertrophic Cardiomyopathy to Assess the Relationship of Early Systolic Left Ventricular Flow and the Mitral Valve. Journal of the American College of Cardiology. 2014; 64: 1984\u20131995.","DOI":"10.1016\/j.jacc.2014.04.090"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Levine RA, Schwammenthal E, Song J. Diastolic leading to systolic anterior motion: new technology reveals physiology. Journal of the American College of Cardiology. 2014; 64: 1996\u20131999.","DOI":"10.1016\/j.jacc.2014.09.010"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Sherrid MV, Gunsburg DZ, Moldenhauer S, Pearle G. Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 2000; 36: 1344\u20131354.","DOI":"10.1016\/S0735-1097(00)00830-5"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020; 142: e558\u2013e631.","DOI":"10.1161\/CIR.0000000000000945"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). European Heart Journal. 2014; 35: 2733\u20132779.","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Lam MT, Wu JC. Biomaterial applications in cardiovascular tissue repair and regeneration. Expert Review of Cardiovascular Therapy. 2012; 10: 1039\u20131049.","DOI":"10.1586\/erc.12.99"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"van Herwerden LA, Ten Cate FJ. Combined anterior mitral leaflet extension and spark erosion myectomy in hypertrophic obstructive cardiomyopathy: Echo-enhanced surgery. Operative Techniques in Thoracic and Cardiovascular Surgery. 2004; 9: 310\u2013319.","DOI":"10.1053\/j.optechstcvs.2004.10.004"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"van der Lee C, Kofflard MJM, van Herwerden LA, Vletter WB, ten Cate FJ. Sustained improvement after combined anterior mitral leaflet extension and myectomy in hypertrophic obstructive cardiomyopathy. Circulation. 2003; 108: 2088\u20132092.","DOI":"10.1161\/01.CIR.0000092912.57140.14"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Vriesendorp PA, Schinkel AFL, Soliman OII, Kofflard MJM, de Jong PL, van Herwerden LA, et al. Long-term benefit of myectomy and anterior mitral leaflet extension in obstructive hypertrophic cardiomyopathy. American Journal of Cardiology. 2015; 115: 670\u2013675.","DOI":"10.1016\/j.amjcard.2014.12.017"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography. 2015; 28: 1\u201339. e14.","DOI":"10.1016\/j.echo.2014.10.003"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Turvey L, Augustine DX, Robinson S, Oxborough D, Stout M, Smith N, et al. Transthoracic echocardiography of hypertrophic cardiomyopathy in adults: a practical guideline from the British Society of Echocardiography. Echo Research and Practice. 2021; 8: G61\u2013G86.","DOI":"10.1530\/ERP-20-0042"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, et al. Current and Evolving Echocardiographic Techniques for the Quantitative Evaluation of Cardiac Mechanics: ASE\/EAE Consensus Statement on Methodology and Indications endorsed by the Japanese Society of Echocardiography. Journal of the American Society of Echocardiography. 2011; 24: 277\u2013313.","DOI":"10.1016\/j.echo.2011.01.015"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: a Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography. 2017; 30: 303\u2013371.","DOI":"10.1016\/j.echo.2017.01.007"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Raut M, Maheshwari A, Swain B. Awareness of \u2019Systolic Anterior Motion\u2019 in Different Conditions. Clinical Medicine Insights: Cardiology. 2018; 12: 1179546817751921.","DOI":"10.1177\/1179546817751921"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Mihos CG, Pineda AM, Horvath SA, Santana O. Anterior Mitral Leaflet Augmentation for Ischemic Mitral Regurgitation Performed via a Right Thoracotomy Approach. Innovations. 2016; 11: 298\u2013300.","DOI":"10.1177\/155698451601100413"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. Journal of the American College of Cardiology. 2014; 64: 83\u201399.","DOI":"10.1016\/j.jacc.2014.05.003"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Silbiger JJ. Abnormalities of the Mitral Apparatus in Hypertrophic Cardiomyopathy: Echocardiographic, Pathophysiologic, and Surgical Insights. Journal of the American Society of Echocardiography. 2016; 29: 622\u2013639.","DOI":"10.1016\/j.echo.2016.03.003"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Delling FN, Sanborn DY, Levine RA, Picard MH, Fifer MA, Palacios IF, et al. Frequency and mechanism of persistent systolic anterior motion and mitral regurgitation after septal ablation in obstructive hypertrophic cardiomyopathy. American Journal of Cardiology. 2007; 100: 1691\u20131695.","DOI":"10.1016\/j.amjcard.2007.07.020"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Sherrid MV, Chu CK, Delia E, Mogtader A, Dwyer EM Jr. An echocardiographic study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 1993; 22: 816\u2013825.","DOI":"10.1016\/0735-1097(93)90196-8"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Cui H, Schaff HV, Abel MD, Helder MRK, Frye RL, Ommen SR, et al. Left ventricular ejection hemodynamics before and after relief of outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy and valvular aortic stenosis. Journal of Thoracic and Cardiovascular Surgery. 2020; 159: 844\u2013852. e1.","DOI":"10.1016\/j.jtcvs.2019.03.071"},{"key":"ref22","unstructured":"Tang B, Song Y, Yang Q, Cui H, Ji K, Zhao S, et al. Changes in left atrial function, left ventricle remodeling, and fibrosis after septal myectomy for obstructive hypertrophic cardiomyopathy. Journal of Thoracic and Cardiovascular Surgery. 2020. (in press)"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Maron BJ. Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation. 2007; 116: 196\u2013206.","DOI":"10.1161\/CIRCULATIONAHA.107.691378"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Moravsky G, Bruchal-Garbicz B, Jamorski M, Ralph-Edwards A, Gruner C, Williams L, et al. Myocardial Mechanical Remodeling after Septal Myectomy for Severe Obstructive Hypertrophic Cardiomyopathy. Journal of the American Society of Echocardiography. 2013; 26: 893\u2013900.","DOI":"10.1016\/j.echo.2013.05.012"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Wei LM, Thibault DP, Rankin JS, Alkhouli M, Roberts HG, Vemulapalli S, et al. Contemporary Surgical Management of Hypertrophic Cardiomyopathy in the United States. Annals of Thoracic Surgery. 2019; 107: 460\u2013466.","DOI":"10.1016\/j.athoracsur.2018.08.068"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Tower-Rader A, Mohananey D, To A, Lever HM, Popovic ZB, Desai MY. Prognostic Value of Global Longitudinal Strain in Hypertrophic Cardiomyopathy: A Systematic Review of Existing Literature. JACC: Cardiovascular Imaging. 2019; 12: 1930\u20131942.","DOI":"10.1016\/j.jcmg.2018.07.016"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008; 117: 1717\u20131731.","DOI":"10.1161\/CIRCULATIONAHA.107.653584"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. Journal of Thoracic and Cardiovascular Surgery. 2010; 139: 1316\u20131324.","DOI":"10.1016\/j.jtcvs.2009.11.020"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Denault AY, Pearl RG, Michler RE, Rao V, Tsui SSL, Seitelberger R, et al. Tezosentan and right ventricular failure in patients with pulmonary hypertension undergoing cardiac surgery: the TACTICS trial. Journal of Cardiothoracic and Vascular Anesthesia. 2013; 27: 1212\u20131217.","DOI":"10.1053\/j.jvca.2013.01.023"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Buckberg GD, Coghlan HC, Hoffman JI, Torrent-Guasp F. The structure and function of the helical heart and its buttress wrapping. VII. Critical importance of septum for right ventricular function. Seminars in Thoracic and Cardiovascular Surgery. 2001; 13: 402\u2013416.","DOI":"10.1053\/stcs.2001.29961"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Hiemstra YL, Debonnaire P, Bootsma M, Schalij MJ, Bax JJ, Delgado V, et al. Prevalence and Prognostic Implications of Right Ventricular Dysfunction in Patients with Hypertrophic Cardiomyopathy. American Journal of Cardiology. 2019; 124: 604\u2013612.","DOI":"10.1016\/j.amjcard.2019.05.021"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Kaple RK, Murphy RT, DiPaola LM, Houghtaling PL, Lever HM, Lytle BW, et al. Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Annals of Thoracic Surgery. 2008; 85: 1527\u20131522.","DOI":"10.1016\/j.athoracsur.2008.01.061"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Sherrid MV, Balaram S, Kim B, Axel L, Swistel DG. The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: a Test in Context. Journal of the American College of Cardiology. 2016; 67: 1846\u20131858.","DOI":"10.1016\/j.jacc.2016.01.071"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Rowin EJ, Maron BJ, Maron MS. The Hypertrophic Cardiomyopathy Phenotype Viewed through the Prism of Multimodality Imaging: clinical and etiologic implications. JACC: Cardiovascular Imaging. 2020; 13: 2002\u20132016.","DOI":"10.1016\/j.jcmg.2019.09.020"},{"key":"ref35","unstructured":"Vincentelli A, Zegdi R, Prat A, Lajos P, Latr\u00e9mouille C, LeBret E, et al. Mechanical modifications to human pericardium after a brief immersion in 0.625% glutaraldehyde. Journal of Heart Valve Disease. 1998; 7: 24\u201329."},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Chauvaud S, Jebara V, Chachques JC, el Asmar B, Mihaileanu S, Perier P, et al. Valve extension with glutaraldehyde-preserved autologous pericardium. Results in mitral valve repair. Journal of Thoracic and Cardiovascular Surgery. 1991; 102: 171\u2013178.","DOI":"10.1016\/S0022-5223(19)36548-1"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Mihos CG, Pineda AM, Capoulade R, Santana O. A Systematic Review of Mitral Valve Repair with Autologous Pericardial Leaflet Augmentation for Rheumatic Mitral Regurgitation. Annals of Thoracic Surgery. 2016; 102: 1400\u20131405.","DOI":"10.1016\/j.athoracsur.2016.04.009"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Carpentier A, Dubost C, Lane E, Nashef A, Carpentier S, Relland J, et al. Continuing improvements in valvular bioprostheses. Journal of Thoracic and Cardiovascular Surgery. 1982; 83: 27\u201342.","DOI":"10.1016\/S0022-5223(19)37322-2"},{"key":"ref39","unstructured":"Carpentier A, Nashef A, Carpentier S, Ahmed A, Goussef N. Techniques for prevention of calcification of valvular bioprostheses. Circulation. 1984; 70: I165\u2013I168."},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Mihos CG, Horvath SA, Fernandez R, Nappi F, Xydas S. Early failure of mitral valve repair with anterior leaflet pericardial patch augmentation in rheumatic and radiation-induced valvulitis. Journal of Thoracic Disease. 2020; 12: 2977\u20132982.","DOI":"10.21037\/jtd.2020.01.20"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Khamooshian A, Buijsrogge MP, de Heer F, Gr\u00fcndeman PF. Mitral valve annuloplasty rings: review of literature and comparison of functional outcome and ventricular dimensions. Innovations. 2014; 9: 399\u2013415.","DOI":"10.1177\/155698451400900603"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/22\/3\/10.31083\/j.rcm2203107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T17:38:27Z","timestamp":1732729107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/22\/3\/10.31083\/j.rcm2203107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"alternative-id":["1632453101696-1540884718"],"URL":"https:\/\/doi.org\/10.31083\/j.rcm2203107","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"article-number":"983"}}